<SEC-DOCUMENT>0001062993-25-001904-index.html : 20250207
<SEC-HEADER>0001062993-25-001904.hdr.sgml : 20250207
<ACCEPTANCE-DATETIME>20250207183428
ACCESSION NUMBER:		0001062993-25-001904
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250201
FILED AS OF DATE:		20250207
DATE AS OF CHANGE:		20250207

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Morrow Phuong Khanh
		CENTRAL INDEX KEY:			0001928989
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36569
		FILM NUMBER:		25603174

	MAIL ADDRESS:	
		STREET 1:		C/O CRISPR THERAPEUTICS
		STREET 2:		610 MAIN STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lantheus Holdings, Inc.
		CENTRAL INDEX KEY:			0001521036
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				352318913
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862
		BUSINESS PHONE:		978 671-8001

	MAIL ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lantheus MI Holdings, Inc.
		DATE OF NAME CHANGE:	20110517
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<DESCRIPTION>INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
<TEXT>
Document 1 - file: form3.html

Document 1 - RAW XML: form3.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>exhibit24.txt
<TEXT>
Document 2 - file: exhibit24.txt

</DOCUMENT>
</SEC-DOCUMENT>